Form D · Venture Capital Fund

TVM Life Science Innovation II SCSp

Senningerberg, N4 · CIK 0001767198

Offering snapshot reported Oct 19, 2020 · SEC filing

Reported sold: $369M
Investors reported: 276
Minimum accepted: $250K
First sale: Dec 17, 2018

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$60,750,000 → $368,950,000
Reported investors9 → 276

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 19, 2020	Amendment	$368,950,000	$308,200,000vs Feb 8, 2019	276	SEC filing
Feb 8, 2019	Initial	$60,750,000	No comparison	9	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $15.4M (estimated)
Finders' fees: $475K (estimated)
Form D file number: 021-332471

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
OCP Capital, LLC	143381
Morgan Stanley	149777

Source: Form D, filed Oct 19, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

TVM LIFE SCIENCE INNOVATION II SCSP

Investment adviser: TVM LIFE SCIENCE MANAGEMENT, INC.

Gross asset value: $430M
Beneficial owners: 250
ADV minimum commitment: $5M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator AZTEC GROUP LUXEMBOURG, Luxembourg Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG LUXEMBOURG, SOCIETE COOPERATIVE LUXEMBOURG, Luxembourg

Custodian J.P. MORGAN SECURITIES LLC BOSTON, Massachusetts, United States Related to adviser: No

Marketer OCP CAPITAL, LLC NEW YORK, New York, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: Yes

KPMG LUXEMBOURG, SOCIETE COOPERATIVE
PCAOB 2831

J.P. MORGAN SECURITIES LLC
SEC 8-35008

OCP CAPITAL, LLC
CRD 143381 · SEC 8-67556

Filing source

Form ADV 2075823 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-4015456079

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
N/A Tvm Life Science Innovation Ii (Gp) S.A.R.L.	Executive
N/A Tvm Life Science Management, Inc.	Executive
N/A Tvm Life Science Ventures Viii (Gp) S.A.R.L.	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

8, Rue Lou Hemmer
Senningerberg, N4, L-1748